Skip to main content
Premium Trial:

Request an Annual Quote

Nuvelo s Revenues Drop Sharply, Net Loss Decreases

NEW YORK, Feb. 6 (GenomeWeb News) - Nuvelo yesterday reported a sharp drop in revenues, along with narrowing losses, for the fourth quarter of 2003.

 

Nuvelo, which resulted from a merger of Hyseq and Variagenics, booked $350,000 in revenues for the quarter, down from $3.5 million a year ago.

 

R&D expenses decreased to $6.7 million, from $9.3 million during the year-ago period.

 

The company's net loss was $9.4 million, or $.12 per share, down from $16.5 million, or $.72 per share, during the same period last year.

 

As of Dec.31, Sunnyvale, Calif.-based Nuvelo had $34.7 million in cash, cash equivalents, short-term investments, and restricted cash.

 

The Scan

Mosquitos Genetically Modified to Prevent Malaria Spread

A gene drive approach could be used to render mosquitos unable to spread malaria, researchers report in Science Advances.

Gut Microbiomes Allow Bears to Grow to Similar Sizes Despite Differing Diets

Researchers in Scientific Reports find that the makeup of brown bears' gut microbiomes allows them to reach similar sizes even when feasting on different foods.

Finding Safe Harbor in the Human Genome

In Genome Biology, researchers present a new approach to identify genomic safe harbors where transgenes can be expressed without affecting host cell function.

New Data Point to Nuanced Relationship Between Major Depression, Bipolar Disorder

Lund University researchers in JAMA Psychiatry uncover overlapping genetic liabilities for major depression and bipolar disorder.